by Daniel X. Thomas
The patent relates to the delivery of mRNA for the augmentation of proteins and enzymes in human genetic diseases.
Brief outline of the case
The MR in opposition corresponded to the claims as granted with the deletion of claim 20.
The OP decided that claim 1 of the MR infringed Art 123(2) and that claim 1 of AR1 suffered a lack of sufficiency.
by Daniel X. Thomas
The patent relates to an optically variable security element and a method of manufacturing it.
Brief outline of the case
In reply to an opposition, the proprietor filed a new MR consisting of a plurality of independent claims.
The new MR was lacking N over D1=EP 2 727 742
The OD decided maintenance according to AR1,
by Daniel X. Thomas
The patent, EP 3 295 663 B1, relates to a digital overlay in a captured image, for instance an overlay in the image captured by a TV camera, so that occlusion of the real captured image is overcome.
Brief outline of the case
AIM SPORT DEVELOPMENT AG, holder of EP 3 295 663 B1,
by Daniel X. Thomas
The patent relates to immune molecules expressed in cancer tissue, and more particularly to evaluating the expression of immune molecules in tumour cells and tumour-infiltrating leukocytes, and especially B7-H1 AND PD-1 in treatment of renal carcinoma.
Brief outline of the case
The OD found that the priority of P1 was not validly claimed and D16,
by Daniel X. Thomas
The patent relates to a enterically coated cysteamine bitartrate and cystamine composition useful for treating cystinosis and neurodegenerative diseases such as Huntington’s, Alzheimer’s and Parkinson’s disease,
The patent results from a divisional application of EP 1 919 458.
Brief outline of the case
The opposition was rejected and the opponent appealed.